维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Zarour"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	NY-ESO-1 encodes DRB1 * 0401-restricted epitopes recognized by melanoma-reactive CD4 + T cells显示文摘	Zarour H M Storkus W J Brusic V		0，，17：	1
2	Immunotherapy in lung cancer显示文摘	Villaruz LC Kalyan A Zarour H	2014	Translat Lung Cancer Res2014，3，1：	1
3	The optimal succinylcholine dosefor intubating emergency patients: retrospective comparative study 显示文摘	Ezzat A Fathi E Zarour A	2011	Libyan J Med2011，6，：	1
4	Emerging therapies in castrate-resistant prostate cancer显示文摘	Zarour L Alumkal J	2010	Curt Urol Rep2010，11，3：	1
5	NY-ESO-1 119-143 is promiscuous major histocompatibility complex class Ⅱ Thelper epitope recognized by Th1-and Th2-type tumor-reactive CD4+ T cells显示文摘	Zarour H M Maillere B Brusic V Coval K Willams E Pouvelle-Moratille S		0，，：	1
6	Physico-chemical and Microbiological Analysis of Algerian Raw Camel's Milk and Identification of Predominating Thermophilic Lactic Acid Bacteria显示文摘	Merzouk Yamina Chahrour Wassila Zarour Kenza Zergui Amina Saidi Noureddine Henni Jamal Eddine Kihal Mebrouk	2013	Journal of Food Science and Engineering2013，3，2：	1
7	NY-ESO-1 encodes DRB1 0401-restricted epitopes recognized by melanoma-reactive CD4^ + T cells 显示文摘	Zarour H M Storkus W J Brusic V	2000	Cancer Res2000，60，17：	1
8	Dendritic cell/peptide cancer vaccines: clinical responsiveness and epitope spreading 显示文摘	Ranieri E Kierstead LS Zarour H	2000	Immanol Invest2000，，：	1
9	NY-ESO-1 119-143 is promiscuous major histocompatibility complex class H T-helper epitope recognized by Thl-and Th2-type tumor-reactiveCD4+ T cells显示文摘	Zarour HM Maillere B Brusic V	2002	Cancer Res2002，62，1：	1
10	Dendritic cell peptide cancer vaccines:clinical responsiveness and epitope spreading显示文摘	Ranieri E Kierstead LS Zarour H	2000	Immunol Invest2000，29，2：	1
11	NY-ESO-1 119- 143 is a promiscuous major histocompatibility complex class Ⅱ T helper epitope recognized by Thl-and Th2-type tumor-reactive CD4 + T cells 显示文摘	Zarour HM Maillere B Brusic V	2002	Cancer Res2002，62，1：	1
12	NY-ESO-1 119-143is promiscuous major histocompatibility complex class Ⅱ Thelper epitope recognized by Th1- and Th2-type tumorreactive CD4+ T cells 显示文摘	Zarour HM Maillere B Brusic V	2002	Cancer Res2002，62，1：	1
13	MelanA/MART151-73 represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4+ T cells显示文摘	Kirkwood JM Kierstead LS	2000	Proc Natl Acad Sci USA2000，97，：	1
14	Dendritic cell/peptide cancer vaccines: clinical responsiveness and epitope spreading 显示文摘	Ranieri E Kierstead L S Zarour H	2000	Immunol Invest2000，29，2：	1
15	Reversing T-cell dysfunction and exhaustion in cancer显示文摘	Zarour HM	2016	Clin Cancer Res2016，22，8：	1
16	Direct product profitability and retail shelf-space allocation models 显示文摘	Bookbinder J H Zarour F H	2001	Journal of Business Logistics2001，22，2：	1
17	MelanA/MART151-73 represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4 + T cells 显示文摘	Kirkwood JM Kierstead LS	2000	Proc Natl Acad Sci USA2000，97，：	1
18	Immunotherapy in lung cancer 显示文摘	Villaruz LC Kalyan A Zarour H	2014	Translat Lung Cancer Res2014，3，1：	1
19	Immunomodalatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma : the E2690 laboratory corollaryof intergroup adjuvant trial E1690 显示文摘	Kirkwood JM Richards T Zarour HM	2002	Cancer2002，95，：	1
20	Emerging therapies in castrate- resistant prostate cancer 显示文摘	Zarour L A\|umkal J	2010	Curr Urol Rep2010，11，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示